Manufacturing

The containment of highly potent active pharmaceutical ingredients

Pharmaceutical production has deeply changed since the last two decades, and highly potent active pharmaceutical ingredients (HPAPIs) play now a increasing central role in...

The new FDA guidelines on Quality Metrics

The new Food and Drug Administration (FDA) guideline “Submission of quality metrics data – Guidance for industry” was published at the end of November...

Glabal Report

Rare diseases. Orphan drug market

Orphan drugs set to be 21.4% of worldwide prescription sales by 2022 (excluding generics). The development of orphan drugs has been financially incentivised through...

Italian APIs producers have won the challenge

The trend has been inverted and Italy is again at the global top ranking as for manufacturing of active pharmaceutical ingredients. The new challenges...

R&D

Company

Viela Bio, a new biotech company of the AstraZeneca’s galaxy

Viela Bio is a new, independent biotech company born from MedImmune - AstraZeneca’s global biologics research...

Pre-seed investments in Israel for Merck

ExploreBio is the new pre-seed-investment vehicle targeted at funding biotech early-stage companies and providing also management...

Acquisition for Roche in e-health records management

The Swiss big pharma company Roche has acquired the 100% shares of Flatiron Health, a...

A new biotech facility for Ferring

Ferring Pharmaceuticals is going to invest approx. CHF 30 million to built its new Ferring...

Nestlè Health Science and the Therapeutic nutrition. The new frontier is opening for better outcomes

Borned in 2011 on the basis of the previous division of HealthCare Nutrition of the...

Merck expands its global biodevelopment capacity

World's oldest pharmaceutical and chemical company Merck announced the expansion of its end-to-end biodevelopment centers,...